We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

Back to rankings

138 hedge funds and large institutions have $227M invested in DIPLOMAT PHARMACY, INC. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $536K

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

2% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 43

1% more funds holding

Funds holding: 137 → 138 (+1)

28% less capital invested

Capital invested by funds: $317M → $227M (-$90M)

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
44
Reduced
43
Closed
34
Calls
$2.56M
Puts
$536K
Net Calls
+$2.03M
Net Calls Change
-$946K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$11M
2
OAC
OMERS Administration Corp
Ontario, Canada
+$10.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.02M
4
OAM
Oxford Asset Management
United Kingdom
+$6.34M
5
SI
Stephens Inc
Arkansas
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$26.5M
2
Capital World Investors
Capital World Investors
California
-$17.1M
3
Capital International Investors
Capital International Investors
California
-$16.2M
4
DM
Deerfield Management
New York
-$14.7M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
LIA
126
LS Investment Advisors
Michigan
$8K – – –
CP
127
Corbenic Partners
Pennsylvania
$8K +$9.39K +2,000 New
VCM
128
Versant Capital Management
Arizona
$7K -$3.14K -668 -27%
CFD
129
Creative Financial Designs
Indiana
$3K – – –
PNC Financial Services Group
130
PNC Financial Services Group
Pennsylvania
$2K -$13.6K -2,900 -88%
OPS
131
Orion Portfolio Solutions
Nebraska
$2K +$1.83K +389 New
GI
132
Gradient Investments
Minnesota
$2K +$2.35K +500 New
CG
133
Cutler Group
California
$1K -$102K -21,632 -99%
GT
134
Glenmede Trust
Pennsylvania
$1K – – –
US Bancorp
135
US Bancorp
Minnesota
$1K +$1.4K +297 New
APA
136
American Portfolios Advisors
New York
$576 – – –
AC
137
Armistice Capital
New York
– -$26.5M -5,400,000 Closed
Capital World Investors
138
Capital World Investors
California
– -$17.1M -3,487,620 Closed
Capital International Investors
139
Capital International Investors
California
– -$16.2M -3,309,527 Closed
DM
140
Deerfield Management
New York
– -$14.7M -2,996,328 Closed
RPAM
141
Rhenman & Partners Asset Management
Sweden
– -$5.19M -1,060,000 Closed
MCM
142
Matarin Capital Management
New York
– -$3.25M -663,050 Closed
ASN
143
Advisory Services Network
Georgia
– -$3.65M -598,802 Closed
FCM
144
Frontier Capital Management
Massachusetts
– -$1.93M -392,928 Closed
TCM
145
Tekla Capital Management
Massachusetts
– -$1.05M -214,845 Closed
State of Wisconsin Investment Board
146
State of Wisconsin Investment Board
Wisconsin
– -$780K -159,100 Closed
AIMCA
147
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$408K -83,200 Closed
Russell Investments Group
148
Russell Investments Group
United Kingdom
– -$358K -72,964 Closed
AG
149
Aperio Group
California
– -$186K -37,901 Closed
Jacobs Levy Equity Management
150
Jacobs Levy Equity Management
New Jersey
– -$135K -27,500 Closed
3 4 5
6
7

DPLO Hedge Fund Activity: Q4 2019 in Review

138 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2019, worth a combined $227M — down 28% from $317M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new DPLO positions and 34 closed out — a net gain of 1 holder — while 44 added to existing stakes and 43 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $11M. The largest seller was Armistice Capital, exiting entirely with an estimated $26.5M sold.

  • 138 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2019, up from 137 in Q3 2019.
  • Funds reported $227M of DIPLOMAT PHARMACY, INC. stock for Q4 2019, down 28% quarter-over-quarter.
  • 35 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2019 and 34 closed out, a net change of +1 holder.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2019 was Renaissance Technologies, an estimated $11M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2019 was Armistice Capital, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2019.